Putting Patients First Blog

SEPTEMBER 3, 2024

Overall, while the NHC appreciates CMS’ intent to streamline the data submission process and make it more accessible, we encourage ongoing dialogue and adjustments to ensure that the process remains patient-centered, efficient, and capable of capturing the full spectrum of information necessary to inform meaningful drug price negotiations.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

Proxsys Rx

MARCH 23, 2023

The cost of prescription non-adherence to the community at large — which ultimately pays for uncompensated care (particularly for hospital readmissions) — is staggering. It’s an absolutely sound business model for a tremendous amount of prescriptions, at least where out-of-pocket costs to patients is concerned.

Drug Pricing 52

Drug Pricing Hospitals Prescription Filling Dosage 52

Putting Patients First Blog

JANUARY 27, 2025

However, the scope and complexity of the proposed rule may present implementation challenges. Standardized templates can help eliminate ambiguities, ensuring that all essential information is presented in an accessible and user-friendly manner. Issue Brief: Improving Prescription Drug Price and Cost Transparency.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Safe Biologics

MARCH 10, 2025

This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. What Will 2025 Mean for Medicare Drug Price Setting Under the IRA?

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130